CardioNet Announces Launch of Clinical Indicator for Sleep Disorders

CardioNet, Inc. (NASDAQ:BEAT) today announced the launch of SomNet �, a new clinical indicator available in the Company�s existing Mobile Cardiac Outpatient Telemetry� (MCOT�) system. Because many patients with cardiac disorders also suffer from common sleep disorders like sleep apnea, CardioNet believes that SomNet has the potential to identify patients with a high likelihood of such sleep disorders by measuring cyclic variation of heart rate (CVHR), a rhythm that is caused by repeated arousals from sleep due to such disorders. SomNet�s utility is based on data presented at the Heart Rhythm Society�s (HRS) 30th Annual Scientific Sessions in Boston.

�There is a high prevalence of sleep disorders like sleep apnea in the cardiovascular and arrhythmia population,� said Randy Thurman, CEO of CardioNet. �The data collected by SomNet is extremely valuable information that can be captured from our existing MCOT ECG signal. If clinically appropriate, physicians may choose to refer patients with CVHR patterns to sleep centers for further diagnostic testing, to determine if they have sleep apnea or another serious sleep disorder.�

In an 80-patient study presented today at HRS, Phyllis K. Stein, Ph.D., Research Associate Professor of Medicine at Washington University School of Medicine, found that automated identification of clinically relevant CVHR is feasible using CardioNet�s MCOT system. The study compared MCOT automatic analysis of CVHR patterns versus a human expert�s direct analysis of plots of HR patterns for measuring clear (large amplitude) CVHR. Findings showed similar specificity and positive predictive value measures between MCOT and human expert analysis, with slightly lower sensitivity measures for the automated analysis.

�Although slightly less sensitive than more labor intensive human overreading, the MCOT system and SomNet may provide a platform for efficiently identifying patients with severe sleep disorders, like sleep apnea, in a large population,� said Dr. Stein.

About CardioNet, Inc.

CardioNet, Inc. is the leading provider of ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health. CardioNet's initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, with a solution that it markets as Mobile Cardiac Outpatient Telemetry� (MCOT�). More information can be found at http://www.cardionet.com.

Forward Looking Statements

This press release includes certain forward-looking statements within the meaning of the �Safe Harbor� provisions of the Private Securities Litigation Reform Act of 1995 regarding, among other things, our growth prospects, the prospects for our products and our confidence in the Company�s future. These statements may be identified by words such as �expect,� �anticipate,� �estimate,� �intend,� �plan,� �believe,� �promises� and other words and terms of similar meaning. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including important factors that could delay, divert, or change any of them, and could cause actual outcomes and results to differ materially from current expectations. These factors include, among other things, the success of our sales and marketing initiatives, our ability to attract and retain talented executive management and sales personnel, our ability to identify acquisition candidates, acquire them on attractive terms and integrate their operations into our business, the commercialization of new products, market factors, internal research and development initiatives, partnered research and development initiatives, competitive product development, changes in governmental regulations and legislation, changes to reimbursement levels for our products, the continued consolidation of payors, acceptance of our new products and services and patent protection and litigation. For further details and a discussion of these and other risks and uncertainties, please see our public filings with the Securities and Exchange Commission, including our latest periodic reports on Form 10-K and 10-Q. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024